A new strategy for prenatal diagnosis of homozygous α0- thalassemia

Ultrasound in Obstetrics and Gynecology

Volumn 28, Issue 2, 2006, Pages 173-177

  Leung, K Y ^a   Liao, C ^d   Li, Q M ^d   Ma, S Y ^d   Tang, M H Y ^b   Lee, C P ^a   Chan, V ^a   Lam, Y H ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TSAN YUK HOSPITAL   (Hong Kong)

^c Hong Kong Prenatal Diagnosis Center   (Hong Kong)

^d GUANGZHOU MATERNAL AND NEONATAL HOSPITAL   (China)

Author keywords

0 thalassemia; Cardiomegaly; Hb Bart's disease; Placenta; Prenatal diagnosis; Prenatal ultrasonography

Indexed keywords

HEMOGLOBIN;

ALPHA THALASSEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HEMOGLOBIN ANALYSIS; HIGH RISK PREGNANCY; HOMOZYGOSITY; HUMAN; OUTCOME ASSESSMENT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

ALPHA-THALASSEMIA; CARDIOMEGALY; DNA; FEMALE; HEMOGLOBINS; HOMOZYGOTE; HUMANS; PREGNANCY; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 33747627169     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.2720     Document Type: Article

References (23)

1. Todd D, Lai MCS, Braga CA. Thalassemia and hydrops fetalis-family studies. BMJ 1967; 3: 347-352.
2. Weatherall DJ, Clegg JB, Wong HB. The hemoglobin constitution of infants with hemoglobin Bart's hydrops fetalis syndrome. Br J Haematol 1970; 18: 357-367.
3. Liang ST, Wong V, So WK, Ma HK, Chan V, Todd D. Homozygous α-thalassemia: clinical presentation, diagnosis and management. A review of 46 cases. Br J Obstet Gynaecol 1985; 92: 680-684.
4. Singer ST, Styles L, Bojanowski J, Quirolo K, Foote D, Vichinsky EP. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol 2000; 22: 539-542.
5. Zeng YT, Huang SZ. Disorders of hemoglobin in China. J Med Genet 1987; 24: 578-583.
6. Lau YL, Chan LC, Chan AYY, Hu SY, Yeung CY, Waye JS, Chui DHK. Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong- implications for population screening. N Engl J Med 1997; 336: 1298-1301.
7. Ghosh A, Tang MHY, Lam YH, Fung E, Chan V. Ultrasound measurement of placental thickness to detect pregnancies affected by homozygous α-thalassemia-1. Lancet 1994; 344: 988-989.
8. Lam YH, Ghosh A, Tang MHY, Lee CP, Sin SY. Early ultrasound prediction of pregnancies affected by homozygous α-thalassemia-1. Prenat Diagn 1997; 17: 327-332.
9. Lam YH, Tang MHY, Lee CP, Tse HY. Prenatal ultrasonographic prediction of homozygous type 1 alpha-thalassemia at 12-13 weeks of gestation. Am J Obstet Gynecol 1999; 180: 148-150.
10. Tongsong T, Wanapirak C, Sirichotiyakul S. Placental thickness at midpregnancy as a predictor of Hb Bart's Disease. Prenat Diagn 1999; 19: 1027-1030.
11. Tongsong T, Wanapirak C, Sirichotiyakul S, Piyamongkol W, Chanprapaph P. Fetal sonographic cardiothoracic ratio at midpregnancy as a predictor of Hb Bart disease. J Ultrasound Med 1999; 18: 807-811.
12. Tongsong T, Wanapirak C, Sirichotiyakul S, Chanprapaph P. Sonographic markers of hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004; 23: 49-55.
13. Liao C, Mo QH, Li J, Li LY, Huang YN, Hua L, Li QM, Zhang JZ, Feng Q, Zeng R, Zhong HZ, Jia SQ, Cui YY, Xu XM. Carrier screening for α- and β- thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal Hospital. Prenat Diagn 2005; 25: 163-171.
14. Leung KY, Lee CP, Tang MHY, Lau ET, Lee YP, Chan HY, Ma ESK, Chan V. Cost-effectiveness of prenatal screening for thalassemia in Hong Kong. Prenat Diagn 2004; 24: 899-907.
15. Snijders RJ, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, Sabbagha RE, Filkins K, Silver RK, Hogge WA, Ginsberg NA, Beverly S, Morgan P, Blum K, Chilis P, Hill LM, Hecker J, Wapner RJ. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002; 19: 353-359.
16. Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH. Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol 2003; 22: 135-137.
17. Tongsong T, Wanapirak C, Srisomboon J, Piyamongkol W, Sirichotiyakul S. Antenatal sonographic features of 100 alpha-thalassemia hydrops fetalis fetuses. J Clin Ultrasound 1996; 24: 73-77.
18. Lam YH, Ghosh A, Tang MH, Lee CP, Sin SY. Second trimester hydrops fetalis in pregnancies affected by homozygous alpha-thalassemia-1. Prenat Diagn 1997; 17: 267-269.
19. Hernandez-Andrade E, Scheier M, Dezerega V, Carmo A, Nicolaides KH. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops. Ultrasound Obstet Gynecol 2004; 23: 442-445.
20. Leung WC, Oepkes D, Seaward G, Ryan G. Serial sonographic findings of four fetuses with homozygous alpha-thalassemia-1 from 21 weeks onwards. Ultrasound Obstet Gynecol 2002; 19: 56-59.
21. Leung KY, Lee CP, Tang MHY, Chan HY, Chan V. Prenatal diagnosis of alpha-thalassemia in a twin pregnancy. Ultrasound Obstet Gynecol 2005; 25: 201-202.
22. Lam YH, Tang MHY. Middle cerebral artery Doppler study in fetuses with homozygous α-thalassemia-1 at 12-13 weeks of gestation. Prenat Diagn 2002; 22: 56-58.
23. Chan V, Yip B, Lam YH, Tse HY, Wong HS, Chan TK. Quantitative polymerase chain reaction for the rapid prenatal diagnosis of homozygous alpha-thalassemia (Hb Barts hydrops fetalis). Br J Haematol 2001; 115: 341-346.